首页> 外国专利> MAGNETIC ULTRASOUND CONTRAST AGENT COMPOSITION, MAGNETIC ULTRASOUND CONTRAST AGENT, AND MAGNETIC MICROBUBBLE ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREFOR

MAGNETIC ULTRASOUND CONTRAST AGENT COMPOSITION, MAGNETIC ULTRASOUND CONTRAST AGENT, AND MAGNETIC MICROBUBBLE ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREFOR

机译:磁性超声造影剂组合物,磁性超声造影剂和磁性微胶质超声造影剂及其制备方法

摘要

A magnetic ultrasound contrast agent composition, a magnetic ultrasound contrast agent, and a magnetic microbubble ultrasound contrast agent and a preparation method therefor. The magnetic ultrasound contrast agent composition comprises a lipid, a surfactant, and a magnetic nanoparticle; the surfactant consists of a surfactant A and a surfactant B; the surfactant A is in a free state, and the surfactant B is in a bonding state and is modified on the surface of the magnetic nanoparticle; the HLB value of the surfactant A is greater than 8; and with respect to 1 mol of the lipid, the content of the surfactant A is 0.1-1 mol, the content of the surfactant B is 0.1-1 mol, and the content of the magnetic nanoparticle is 0.05-0.5 mol. The magnetic microbubble ultrasound contrast agent obtained from the magnetic ultrasound contrast agent composition has high stability and can meet requirements for in vivo cyclic targeted delivery, thereby achieving the local high-concentration targeted delivery of a medication.
机译:磁性超声造影剂组合物,磁性超声造影剂和磁性微泡超声造影剂及其制备方法。磁性超声造影剂组合物包含脂质,表面活性剂和磁性纳米颗粒;表面活性剂由表面活性剂A和表面活性剂B组成;表面活性剂A处于游离状态,表面活性剂B处于粘合状态,并在磁性纳米粒子的表面上进行改性;表面活性剂A的HLB值大于8;关于1摩尔脂质,表面活性剂A的含量为0.1-1摩尔,表面活性剂B的含量为0.1-1摩尔,磁性纳米粒子的含量为0.05-0.5摩尔。从磁性超声造影剂组合物中获得的磁性微胶质超声造影剂具有高稳定性,并且可以满足体内循环靶向递送的要求,从而实现了药物的局部高浓度靶向递送。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号